Endo International has announced the appointment of Craig Paterson, M.D. as Chief Medical Officer. In this new role, Dr. Paterson will report to Susan Hall, Ph.D., Executive Vice President, Chief Scientific Officer and Global Head of Research & Development and Quality, and will be responsible for Endo's global clinical development strategies, execution and lifecycle management as well as that all marketed products and assets under development meet the highest safety and quality standards. Prior to joining Endo, Dr. Paterson held senior level medical and clinical development positions at Salix Pharmaceuticals, King Pharmaceuticals and GlaxoSmithKline.
"Craig's breadth of corporate, clinical and academic experience, coupled with his deep regulatory and drug development skills, make him uniquely qualified for this position at Endo," said Dr. Hall. "As an organization, we remain committed to organic growth and pipeline development. We are very pleased to have someone with Craig's proven expertise join our R&D leadership team during this exciting time of pipeline expansion and corporate growth. We look forward to his leadership and contributions as we move forward with our current and future clinical programs."
"I am tremendously excited to be joining Endo and look forward to supporting the company's product portfolio and advancing its growing range of promising clinical programs, particularly BELBUCA™ and XIAFLEX®," said Dr. Paterson. "My commitment is to work with the team to progress the pipeline and develop products with the potential to meaningfully improve patients' lives."
Prior to joining Endo, Dr. Paterson served as Senior Vice President, Medical and Clinical Development for Salix Pharmaceuticals. In this role, he provided overall leadership for the clinical development, medical affairs and medical science liaisons and drug safety teams, as well as strategic direction to key development projects and the business development function. Prior to his time at Salix, Dr. Paterson served in various roles of increasing responsibility within Medical and Clinical Development at King Pharmaceuticals and GlaxoSmithKline. Dr. Paterson previously served as Chief, Colon and Rectal Surgery, Associate Professor of Surgery at University of Massachusetts Medical School and Assistant Professor of Surgery at McMaster University Medical Center where he was responsible for direct patient care as well as supervision of fellows, surgical residents and medical students.